ClinicalTrials.Veeva

Menu

Imaging Measures of Respiratory Health Registry (iMRH)

University of British Columbia logo

University of British Columbia

Status

Enrolling

Conditions

Healthy
Respiratory Disease

Treatments

Diagnostic Test: 1H and Xe-129 MRI

Study type

Observational

Funder types

Other

Identifiers

NCT05102825
H19-01163

Details and patient eligibility

About

This is a prospective, observational cohort registry that aims to collect data on pulmonary structure and function in healthy people and those with respiratory disease, using structural and functional pulmonary 1H-MRI and hyperpolarized 129Xe-MRI.

Outcome measures generated from MRI may include but are not limited to measures of regional ventilation, pulmonary microarchitecture, and regional gas exchange. Additionally, one of the goals of the registry is to facilitate the development of novel image analysis techniques that have not yet been invented.

These data will be stored along with demographic data, clinical data, and pulmonary function testing (PFT) data.

This is an open registry. Eligible local and international investigators/institutions can apply for access.

Enrollment

1,000 estimated patients

Sex

All

Ages

Under 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Respiratory Disease

Inclusion Criteria:

  1. Physician-diagnosed lung disease - based on a diagnosis made by a treating staff physician and confirmed by the principal investigator.
  2. Age 0-99 years.
  3. Informed consent by participant, parent, or legal guardian
  4. In the opinion of the Investigator, the participant will likely be able to perform maneuvers to obtain technically acceptable pulmonary XeMRI images.

Exclusion Criteria:

  1. Physical findings at screening that, in the opinion of the Investigator, would compromise the safety of the participant or the quality of the research data.
  2. Requirement of supplementary oxygen to maintain an oxygen saturation above 95%.
  3. Failed MRI screening form.
  4. History of claustrophobia.
  5. Known current pregnancy or lactation.

Healthy

Inclusion Criteria:

  1. Age 0-99 years
  2. Informed consent by participant, parent, or legal guardian
  3. In the opinion of the Investigator, the participant will likely be able to perform maneuvers to obtain technically acceptable pulmonary MRI images.

Exclusion Criteria

  1. Physician-diagnosed lung disease.
  2. Failed MRI screening form.
  3. History of claustrophobia.
  4. Physical findings at screening that, in the opinion of the Investigator, would compromise the safety of the participant or the quality of the research data.
  5. Known current pregnancy or lactation.

Trial design

1,000 participants in 2 patient groups

Respiratory Disease
Description:
Any physician-diagnosed lung disease
Treatment:
Diagnostic Test: 1H and Xe-129 MRI
Healthy
Description:
Healthy control with no physician-diagnosed lung disease
Treatment:
Diagnostic Test: 1H and Xe-129 MRI

Trial contacts and locations

2

Loading...

Central trial contact

Rodrigo Sandoval, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems